| Trial ID: | L2976 |
| Source ID: | NCT02236962
|
| Associated Drug: |
Placebo
|
| Title: |
Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Obesity|Cardiovascular Disease
|
| Interventions: |
DRUG: Placebo|DRUG: Ephedrine, pioglitazone
|
| Outcome Measures: |
Primary: brown adipose tissue activity, measured via PET-CT, 3 years |
|
| Sponsor/Collaborators: |
Sponsor: Bayside Health | Collaborators: Baker Heart and Diabetes Institute|The Alfred
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
|
| Enrollment: |
42
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2012-04
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2014-09-11
|
| Locations: |
Alfred Hospital, Melbourne, Victoria, 3004, Australia
|
| URL: |
https://clinicaltrials.gov/show/NCT02236962
|
